Fig. 2From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapyKaplan-Meier curves depicting progression-free survival (PFS) according to CRS (blue line: CRS1/2, red line: CRS3)Back to article page